Yao-Bin Liu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Pluripotent Stem Cells

Ejection Fraction

Peritoneal Dialysis

Top Venues

Cancer research communications

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sapna Yadavilli, Jeremy D Waight, Sara Brett, Meixia Bi, Tianqian Zhang, Yao-Bin Liu, Catherine Ellis, David C Turner, Ashleigh Hahn, Hong Shi, Laura Seestaller-Wehr, Junping Jing, Qing Xie, Jafar Sadik Shaik, Xiao Ji, Robert Gagnon, William Fieles, Laura Hook, Steven Grant, Stephanie Hopley, M Phillip DeYoung, Christina Blackwell, Michael Chisamore, Robert Biddlecombe, David J Figueroa, Christopher B Hopson, Roopa Srinivasan, James Smothers, Michele Maio, Danny Rischin, Daniel Olive, Elaine Paul, Patrick A Mayes, Axel Hoos, Marc Ballas
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade. Cancer research communications 3 (8) (2023)
Cecile Geuijen, Paul Tacken, Liang-Chuan Wang, Rinse Klooster, Pieter Fokko van Loo, Jing Zhou, Arpita Mondal, Yao-Bin Liu, Arjen Kramer, Thomas Condamine, Alla Volgina, Linda J A Hendriks, Hans van der Maaden, Eric Rovers, Steef Engels, Floris Fransen, Renate den Blanken-Smit, Vanessa Zondag-van der Zande, Abdul Basmeleh, Willem Bartelink, Ashwini Kulkarni, Wilfred Marissen, Cheng-Yen Huang, Leslie Hall, Shane Harvey, Soyeon Kim, Marina Martinez, Shaun O'Brien, Edmund Moon, Steven Albelda, Chrysi Kanellopoulou, Shaun Stewart, Horacio G Nastri, Alexander B H Bakker, Peggy Scherle, Ton Logtenberg, Gregory Hollis, John de Kruif, Reid Huber, Patrick A Mayes, Mark Throsby
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade. Nature communications 12 (1) (2021)